Scarica l'app Stockscreener
16.00
8.18%
1.21
Precedente Chiudi:
$14.79
Aprire:
$14.84
Volume 24 ore:
184.22K
Relative Volume:
0.43
Capitalizzazione di mercato:
$1.06B
Reddito:
Utile/perdita netta:
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
1 W Prestazione:
-3.79%
1M Prestazione:
-27.77%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$0.00
$0.00
Intervallo di 1 settimana:
$14.60
$16.89
Portata 52W:
$14.60
$25.93
Latigo Biotherapeutics, Inc. Common Stock Stock (LTGO) Company Profile
Nome
Latigo Biotherapeutics, Inc. Common Stock
Settore
Industria
Telefono
-
Indirizzo
-
Compare LTGO vs VRTX, MRNA, REGN, ARGX, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LTGO
Latigo Biotherapeutics, Inc. Common Stock
|
16.00 | 1.06B | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
508.89 | 128.98B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
212.54 | 84.85B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
765.84 | 78.85B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
818.91 | 51.50B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
192.94 | 41.36B | 742.00K | -1.37B | -1.07B | -7.0731 |
Latigo Biotherapeutics, Inc. Common Stock Stock (LTGO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-09-01 | Iniziato | Goldman | Buy |
| 2026-09-01 | Iniziato | Guggenheim | Buy |
| 2026-09-01 | Iniziato | Jefferies | Buy |
| 2026-09-01 | Iniziato | Leerink Partners | Outperform |
Latigo Biotherapeutics, Inc. Common Stock Borsa (LTGO) Ultime notizie
Latigo Biotherapeutics, Inc. Common Stock (NASDAQ: LTGO) Stock Price, News & Analysis - kalkine.ca
Latigo Biotherapeutics, Inc. Common Stock (LTGO) Earnings Reports & Dates - FXEmpire
Latigo Biotherapeutics Q2 Results: EPS loss narrows 24% YoY - scanx.trade
Latigo Biotherapeutics (LTGO) draws 4.45M-share stake from Deep Track - Stock Titan
Sanofi Converts Series B Preferred Stock and Convertible Note into Latigo Biotherapeutics Common Shares Following IPO - Kalkine Media
Latigo Biotherapeutics Completes IPO and Updates Governance - TipRanks
Latigo Biotherapeutics (LTGO) On IPO And Trial Data Looks About Right Valued - Yahoo Finance
Latigo Biotherapeutics (Nasdaq:LTGO)Stock Analysis - Simply Wall Street
Latigo Biotherapeutics Prices Upsized $345.6 Million Initial Public Offering - quiverquant.com
Latham & Watkins Advises on Latigo Biotherapeutics’ Upsized US$345.6 Million Initial Public Offering - Latham & Watkins LLP
Latigo Biotherapeutics Announces Pricing of Upsized $345.6 Million Initial Public Offering - GlobeNewswire
Latigo Biotherapeutics prices $345.6M IPO at $18 per share - Investing.com
Latigo Biotherapeutics files for Nasdaq IPO at up to $18 per share - Investing.com
Latigo Biotherapeutics files for $256M-$288M Nasdaq IPO - scanx.trade
Latigo Biotherapeutics Commences IPO Process For Pain Treatment Pipeline (Pending:LTGO) - Seeking Alpha
Latigo Biotherapeutics, Inc. Common Stock Azioni (LTGO) Dati Finanziari
Non sono disponibili dati finanziari per Latigo Biotherapeutics, Inc. Common Stock (LTGO). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Latigo Biotherapeutics, Inc. Common Stock Azioni (LTGO) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Tananbaum James B. | Director |
Aug 10 '26 |
Buy |
18.00 |
140,000 |
2,520,000 |
2,008,024 |
5.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):